オプションチェーンは、DatChatの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、DatChatの市場センチメントを評価します。.

DatChat (NASDAQ:DATS) 株価情報, オプションチェーン

DatChat

DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

DatChat Inc

JP Morgan analyst Brian Essex maintains Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) with a Underweight and lowers the price target from $122 to $117.

News

Price Target

Analyst Ratings

QLYS

JP Morgan Maintains Underweight on Qualys, Lowers Price Target to $117

Earnings

Earnings Beats

Earnings Misses

BMRC

Bank of Marin Q1 EPS $0.30 Misses $0.32 Estimate, Sales $27.82M Beat $25.79M Estimate

Management

MongoDB Names Mike Berry CFO, Effective May 27, 2025

Morgan Stanley analyst Tejas Savant downgrades Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) from Overweight to Equal-Weight and lowers the price target from $25 to $15.

Downgrades

AVTR

Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15

JP Morgan analyst Brian Essex maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Overweight and lowers the price target from $53 to $43.

TENB

JP Morgan Maintains Overweight on Tenable Holdings, Lowers Price Target to $43

<h3 class="wp-block-heading">From Fringe to Forefront: The Rise of Mitragynine</h3>
Wellness trends often emerge at the fringes of mainstream attention—passed between friends, spotlighted in boutique retailers, or debated in digital communities. From adaptogenic mushrooms to CBD, the path is familiar: niche adoption turns to broader interest, and eventually, market boom.
Now, a new botanical is following that trajectory: Mitragynine. This naturally occurring alkaloid found in the leaves of Mitragyna speciosa—a tropical tree native to Southeast Asia—is starting to show signs of breaking into the cultural and commercial spotlight. Once relegated to online forums and alternative wellness circles, Mitragynine is now entering the ready-to-drink beverage category, an arena already primed for growth.
<h3 class="wp-block-heading">A Culture Craving Calm</h3>
One of the most telling shifts in consumer behavior over the last five years has been the rise of the "slow wellness" movement. People are no longer chasing overstimulation. Instead, they're seeking clarity without the crash, calm without sedation, and performance without artificiality.
According to a 2024 McKinsey Health report, 76% of consumers now prioritize mental wellness in their daily decisions. That includes beverage choices. Where once energy drinks dominated, today's buyers are exploring functional drinks that align with mood, intention, and long-term wellness.
Mitragynine fits naturally into this narrative. Its mood-balancing, focus-enhancing potential appeals to consumers looking for alternatives to alcohol, synthetic stimulants, and sugar-loaded options. Unlike caffeine-heavy drinks that fuel hustle culture, Mitragynine invites a more centered, aligned approach to productivity and relaxation.
<h3 class="wp-block-heading">Learning from the Botanicals That Came Before</h3>
Mitragynine's current momentum echoes the rise of CBD several years ago. In its early days, CBD experienced scattered adoption, unclear regulatory positioning, and varied product quality. But as interest solidified, the category matured—spurring a wave of investment, innovation, and standardization.
The same dynamics are beginning to unfold with mitragynine. Investors are tracking consumer adoption curves, eyeing brands with clear sourcing, traceability, and scalable operations. And just as CBD's journey paved the way for regulatory frameworks, mitragynine now presents a similar opportunity to bring structure to a still-emerging space.
<h3 class="wp-block-heading">Regulation Isn't a Risk—It's a Catalyst</h3>
Some stakeholders view regulation as a threat. But for operators and investors looking to build responsibly, regulation is a competitive advantage.
When CBD received its first wave of federal guidance, it marked a turning point: brands with transparent practices were rewarded, while opportunists were filtered out. The Mitragynine space is poised for a similar inflection point.
Clear, reasonable guidelines will not only provide consumer safety—they'll also enable retailers, distributors, and investors to engage without fear. That legitimization is what turns a trend into a category.
<h3 class="wp-block-heading">What Investors Should Watch</h3>
So what does "readiness" look like in this space?
It's not just about clever branding. It's about operational infrastructure. Brands that are building vertically integrated supply chains, investing in R&amp;D and formulation expertise, and creating consumer education pathways are positioning themselves to scale sustainably.
We're seeing early signs of capital movement into the category—from angel investors funding beverage startups to CPG veterans entering via joint ventures and partnerships. The next wave will likely bring larger institutional interest, but timing and regulatory positioning will be key.
<h3 class="wp-block-heading">The Road Ahead</h3>
Like all emerging markets, Mitragynine is experiencing its share of skepticism and growing pains. But the parallels with CBD, the rise of mood-forward wellness, and the early retail adoption all point to a category on the cusp of acceleration.
For investors, this is a window—perhaps a brief one—to move early, build responsibly, and shape the narrative around what functional botanicals can offer.
Because this isn't just a plant. It's a paradigm shift in how we think about wellness—and where smart capital goes next.

Cannabis

Opinion

General

The Next Botanical Poised For Breakout Like CBD

KoBold Metals, the mining startup backed by Bill Gates and Jeff Bezos, is ready for a major expansion into the Democratic Republic of Congo (DRC) – a country with a <a target="_blank" href="https://www.benzinga.com/markets/commodities" rel="noreferrer noopener">vast commodity wealth</a>, including cobalt, copper, and lithium.
"KoBold is committed to significant investments in the DRC, potentially amounting to billions of dollars. Our goal is to harness the country's rich mineral resources responsibly and sustainably," Benjamin Katabuka, the firm's newly appointed Director-General in the DRC, <a target="_blank" href="https://www.ft.com/content/3c5859db-2a46-4111-b823-865dc284c33b" rel="noreferrer noopener">said</a> to The Financial Times.
The United States has recently intensified its interest in securing African mineral resources to counter China's dominance. Massad Boulos, President Donald Trump's Senior Adviser for Africa, confirmed that the U.S. and the DRC have "charted a path forward" for a minerals partnership that could enhance American access to lithium, cobalt, and copper—resources critical for electric vehicles and energy storage.
KoBold Metals has shown keen interest in DRC's <a target="_blank" href="https://www.benzinga.com/25/03/44456007/gates-bezos-backed-startup-makes-move-for-dr-congos-lithium" rel="noreferrer noopener">lithium deposits</a>, which could become one of the largest lithium mines globally if legal disputes are resolved. CEO Gerard Barron presented the goal to "responsibly and economically deliver the world's first commercial-scale nodule project."
However, the DRC remains a difficult jurisdiction. Security concerns, such as the ongoing conflict with the M23 rebels, disrupt mining operations, particularly in the eastern regions. Per recent reports, Blackwater founder Erik Prince might provide an <a target="_blank" href="https://www.benzinga.com/news/global/25/04/44885311/blackwater-founder-reaches-a-security-deal-with-dr-congo" rel="noreferrer noopener">initial security deployment</a> in the Katanga province.
Infrastructure challenges, including unreliable energy supplies, further complicate investment. "It's difficult to do business in the DRC," Katabuka acknowledged.
The DRC is the world's leading cobalt supplier and a major copper producer, two elements indispensable for EV batteries and green technologies. Yet, the country has faced criticism for human rights abuses and environmental concerns regarding its <a target="_blank" href="https://www.npr.org/sections/goatsandsoda/2023/02/01/1152893248/red-cobalt-congo-drc-mining-siddharth-kara" rel="noreferrer noopener">mining practices</a>, which NPR dubbed "modern-day slavery."
KoBold's Machine Prospector uses advanced data modeling and AI to systematically analyze geochemical, geophysical, and geological datasets, allowing faster, <a target="_blank" href="https://www.koboldmetals.com/news/robust-and-ethical-cobalt-supply-for-the-electric-vehicle-revolution/" rel="noreferrer noopener">more accurate identification</a> of mineral prospects without relying solely on manual methods. This approach could enable KoBold to develop new, ethical sources of cobalt that meet rising demand.
So far, the firm has raised over $1 billion, with the latest $537 million round with backers such as Breakthrough Energy Ventures, Equinor, Mitsubishi Corporation, and Standard Investments. The firm's leadership, including founder Josh Goldman, has hinted that KoBold may eventually go public, but for now, it remains privately backed and focused on long-term strategic mineral exploration.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/45021300/golds-glitter-fades-what-etf-investors-need-to-know-now" target="_blank" rel="noreferrer noopener">Gold's Glitter Fades? What ETF Investors Need To Know Now</a></li>
</ul>

Emerging Markets

Financing

Commodities

Markets

BATT

CARZ

COPX

CPER

Fidelity Electric Vehicles and Future Transportation ETF

FDRV

JJMTF

KoBold Metals Prepares Billions To Develop Ethical Sources Of Critical Metals In DR Congo

JP Morgan analyst Brian Essex maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Overweight and lowers the price target from $55 to $45.

VRNS

JP Morgan Maintains Overweight on Varonis Systems, Lowers Price Target to $45

<ul>
<li>Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer</li>
<li>NT219's mechanism of action informs how it can restore efficacy of immunotherapies and expand the patient population that can benefit from immunotherapies</li>
</ul>

Biotech

Events

PPBT

Purple Biotech Reports Data At AACR For Colorectal And Head And Neck Cancer

Analyst Ray Wang posted that major U.S. retailers, including Walmart and Target, have reportedly asked&nbsp;Chinese suppliers to resume shipments, with tariffs to be absorbed by the American retailers.
What Happened: On Saturday, Wang posted on X that several Chinese exporters at the ongoing China Import and Export Fair (Canton Fair) revealed that U.S. retail companies, including Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), and Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), have instructed Chinese suppliers to restart shipments that had been halted due to the recent tariff war. 
However, the cost of the tariffs would be borne by the retailers. The decision by these U.S. retailers came after a meeting with President Donald Trump at the White House, as per the report in Hong Kong&#8217;s Ming Pao.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">REPORT: Walmart and Other U.S. Retailers Reportedly Notify Chinese Suppliers to Resume Shipments But Tariffs Cost Will be on U.S. Firms. Several Chinese exporters said that major U.S. retailers, including Walmart, have informed some Chinese suppliers to resume shipments after…
&mdash; Ray Wang (@rwang07) <a href="https://twitter.com/rwang07/status/1916177259632988233?ref_src=twsrc%5Etfw">April 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Exporters mentioned by the Ming Pao report that some orders are resuming, while others have been canceled. Due to high tariffs, US retailers like Walmart must either cancel orders for Chinese products or pass the tariff costs onto American consumers, reported Global Times.
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/04/45003790/mark-cuban-slams-amazon-for-ripping-off-american-sellers-as-tariffs-are-predicted-to-boost-ecommerce-brands-profi" target="_blank" rel="noreferrer noopener">Mark Cuban Slams Amazon For &#8216;Ripping Off American Sellers&#8217; As Trump Tariffs Are Predicted To Boost Ecommerce Brands&#8217; Profits</a>
Why It Matters:&nbsp;This development follows a&nbsp;<a href="https://www.benzinga.com/25/04/44920573/ceos-of-walmart-target-home-depot-meet-trump-to-push-back-on-tariffs-impacting-consumer-prices">meeting</a>&nbsp;between President Trump and the CEOs of Walmart, Home Depot, and Target. The meeting focused on the potential impact of Trump&#8217;s extensive tariff plans on the import-centric business models of these retail giants.
Furthermore, the ongoing U.S.-China trade war has been causing <a href="https://www.benzinga.com/markets/25/04/45008049/shoes-toys-apparel-and-earbuds-may-disappear-from-shelves-first-as-us-china-trade-war-disrupts-supply-chains-retail-experts-warn">potential shortages</a> in key consumer product areas, pushing the national supply chain towards a critical point. The sudden implementation of tariffs left companies with little time to adjust their sourcing strategies.
With the resumption of shipments from Chinese suppliers, these retailers seem to be taking measures to mitigate the impact of the tariff battle on their operations and on American consumers.
Over the past month, Walmart surged 11.7%, while Target declined 6.8%. Meanwhile, Home Depot edged 0.16% lower during the period, as per <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>. 
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/general/sports/25/04/45027895/why-shaq-wont-share-his-500-million-fortune-with-his-kids-we-aint-rich-im-rich-im-not-going-to-hand-it-to-you-you-gotta-earn-it" target="_blank" rel="noreferrer noopener">Why Shaq Won't Share His $500 Million Fortune With His Kids: ‘We Ain't Rich. I'm Rich. I'm Not Going to Hand It to You, You Gotta Earn It&#8217; &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Economics

Walmart, Home Depot, Target Push Chinese Suppliers To Resume Shipments, Agree To Absorb Tariffs: Report

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said he likes BHP Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>). &#8220;I think you got a good situation going there,&#8221; he added.
As CEO Mike Henry&#8216;s tenure approaches its expected conclusion, BHP Group reportedly prepares for a leadership transition. While no formal announcement has been made, company insiders suggested the board could initiate the succession process soon, with a potential <a href="https://www.benzinga.com/25/04/44947180/the-worlds-largest-miner-quietly-prepares-for-ceo-succession">handover in early 2026</a>.
Cramer recommended not selling Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) here. &#8220;I want you to <a href="https://www.benzinga.com/quote/ARM/news">stay in it,&#8221; he added</a>.
As per recent news, Cadence agreed to acquire Arm&#8217;s Artisan Foundation IP business on April 16.
Cramer said no to Strategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), adding he likes Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
According to a recent SEC filing, Strategy acquired an additional 6,556 Bitcoin for approximately $555.8 million. The purchase was made between April 14 and April 20, at an average price of $84,785 per <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44898586/strategy-adds-555-million-in-bitcoin-ups-stash-to-538200-btc">Bitcoin including fees</a>.
Price Action:
<ul>
<li>Arm shares gained 1.2% to settle at $113.34 on Friday.</li>
<li>Strategy shares gained 5.2% to close at $368.71 during the session.</li>
<li>BHP shares fell 2.2% to settle at $48.21 on Friday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45007044/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend-yields-5">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Media

Trading Ideas

$BTC

MSTR

Jim Cramer Likes BHP Group, Recommends Not Selling This Tech Stock

CASK

Heritage Distilling FY24 Adj. EPS $(1.97) Up From $(96.45) YoY; Revenue $8.4M Up From $7.97M YoY

&nbsp;Palo Alto Networks&#xAE; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), the global cybersecurity leader, today announced its latest advancements in <a href="https://www.paloaltonetworks.com/sase">Prisma</a>&#xAE; <a href="https://www.paloaltonetworks.com/sase">SASE</a>, the industry's most comprehensive secure access service edge (SASE) solution, including the unveiling of <a href="https://www.paloaltonetworks.com/sase/prisma-access-browser">Prisma Access Browser</a> 2.0, the world's only SASE-native secure browser. Prisma Access Browser 2.0, along with Endpoint Data Loss Prevention (DLP) and expanded cloud presence with Oracle Cloud Infrastructure (OCI), are new Prisma SASE capabilities designed to secure generative AI (GenAI) usage, improve user experience and enhance operational resilience in the modern workplace.
<a href="https://www.paloaltonetworks.com/resources/infographics/the-state-of-security-in-the-modern-organization">Eighty-five percent</a> of work today is happening in browsers, leading to potential data exposure and monitoring gaps. Palo Alto Networks <a href="https://www.paloaltonetworks.com/resources/research/unit-42-incident-response-report">2025 Unit 42 Incident Report</a> found that almost half (44%) of security incidents involved malicious activities initiated or enabled through employees' browsers, such as phishing, URL redirect abuse and malware downloads.
"A secure browser extends SASE protection to where knowledge workers spend most of their time, securing third-party access, supporting BYOD, and reducing an organization's reliance on legacy infrastructure like VDI," said John Grady, principal analyst at Enterprise Strategy Group, now part of Omdia. "Palo Alto Networks unique approach of integrating its Prisma Access Browser with Prisma SASE helps organizations extend the same protection from advanced threats, user experience monitoring, and GenAI app protection from the network into the browser, ensuring users are protected, efficient, and productive."

PANW

Palo Alto Networks Unveils Prisma Access Browser 2.0, World's Only SASE-Native Secure Browser

On Friday, April 25, U.S. markets closed higher, capping a strong week fueled by easing U.S.-China trade tensions and solid earnings. The S&amp;P 500 and Nasdaq gained, led by AI-related megacaps, while the Dow lagged.
Most S&amp;P 500 firms beat earnings expectations, though forward guidance reflected economic uncertainty. Consumer sentiment stayed weak while Alphabet rallied and Intel slumped.
In economic data, the University of Michigan&#8217;s consumer sentiment index for April was revised up to 52.2, improving from the initial estimate of 50.8 but still down from March&#8217;s 57.
Among the S&amp;P 500&#8217;s 11 major sectors, consumer discretionary and tech led the gains, while materials recorded the biggest percentage decline.
The Dow Jones Industrial Average was up 0.05% to 40,113.50, the S&amp;P 500 rose 0.74% to 5,525.21, and the Nasdaq jumped 1.26% to 17,382.94.
Asia Markets Today
<ul>
<li>On Monday, Japan&#8217;s Nikkei 225 gained 0.35% and closed at 35,831.00, led by gains in the Real Estate, Banking, and Textile sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 gained 0.36%, ending the session at 7,997.10, led by gains in the Energy, IT, and Consumer Discretionary sectors.</li>
<li>India&#8217;s Nifty 50 was up 1.17% at 24,320.35, and Nifty 500 rose 1.13% to 22,094.45.</li>
<li>China&#8217;s Shanghai Composite slid 0.20% to 3,288.41, and Shanghai Shenzhen CSI 300 was down 0.14% at 3,781.62.</li>
<li>Hong Kong&#8217;s Hang Seng closed 0.04% lower at 21,971.96.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 was up 0.79%.</li>
<li>Germany&#8217;s DAX gained 0.83%.</li>
<li>France&#8217;s CAC 40 rose 0.89%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 0.39%.</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.21% at $62.90/bbl, and Brent was down 0.20% at $65.67/bbl.</li>
<li>Natural Gas rose 1.35% to $3.156.</li>
<li>Gold was trading lower by 0.28% at $3,289.40, Silver was down 0.50% to $32.845, and Copper slid 0.53% to $4.8692.</li>
<li>Gold prices fell as easing U.S.-China trade tensions reduced safe-haven demand. Investors await key U.S. data, while Copper edged lower despite hopes for China&#8217;s economic stimulus boost.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were up 0.01%, S&amp;P 500 futures fell 0.10%, and Nasdaq 100 futures declined 0.09%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. Dollar Index rose 0.13% to 99.60, USD/JPY was down 0.15% to 143.46, and USD/AUD gained 0.01% to 1.5628.</li>
<li>Global markets stayed near three-week highs as easing tariff concerns lifted sentiment, though confusion over U.S. trade policy persisted. Stocks rose modestly, the dollar struggled, and investors focused on key U.S. earnings, jobs data, and upcoming elections.</li>
</ul>
Photo via Shutterstock

Asia

Eurozone

Futures

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Advances, Gold Retreats On Hopes Of Fading Uncertainty - Global Markets Today While US Slept

The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for crofelemer for MVID; Click <a href="https://viavid.webcasts.com/starthere.jsp?ei=1718118&amp;tp_key=02fe2f82c4">here</a> to register
There are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management
This data was presented at the <a href="https://www.elite-pedgi.com/">Annual ELITE PED-GI Congress</a> by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology and the primary investigator for this study

JAGX

Jaguar Health To Present Initial Results From Proof-of-Concept Study of Crofelemer For Rare Diseases Microvillus Inclusion Disease And Short Bowel Syndrome With Intestinal Failure

BSRR

Sierra Q1 EPS $0.65 Misses $0.66 Estimate, Sales $36.75M Miss $37.51M Estimate

ZJK Industrial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) reported quarterly earnings of $0.06 per share. This is a 53.85 percent decrease over earnings of $0.13 per share from the same period last year. The company reported $37.81 million in sales this quarter. This is a 30.15 percent increase over sales of $29.05 million the same period last year.

ZJK Industrial FY EPS $0.06 Down From $0.13 YoY, Sales $37.81M Up From $29.05M YoY

Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) reported $1.24 million in sales this quarter. This is a 99.92 percent decrease over sales of $1.50 billion the same period last year.

NEGG

Newegg Commerce FY24 Sales $1.24M Down From $1.50B YoY

Macro Economic Events

Global

Bessent Says India Could Be One Of First Trade Deals We Sign

<ul>
<li>Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups.</li>
<li>Latest data showed Zio LTCM was associated with higher diagnostic yield and lower likelihood of repeat testing and cardiovascular events compared to all other LTCM products.</li>
</ul>
SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Ikwp3f39jnu34tuHM0kHVjLa90aVBTaCBY2hja6eWJExuBXp8_Y6rAsaxWHfbSueKtdCrmddSVqac7FC2MVt8bz0OAy0xibL25f77FW-JPA=">iRhythm Technologies, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society's annual meeting, HRS2025, held April 24–27 in San Diego, CA, The Assessment of Variation in AmbuLatory Cardiac MONitoring: Real-World Evidence of Commercially Insured Beneficiaries (AVALON) study—drawing on claims data from a cohort of 428,707 commercially insured patients—represents the largest real-world comparative evaluation of ambulatory cardiac monitoring (ACM) among this population to date, and reinforces the clinical superiority of the Zio&#xAE; long-term continuous monitoring (LTCM) service.

IRTC

iRhythm Presents AVALON Study Results at HRS2025, Showcasing Largest Real-World ACM Analysis

Press Releases

Dragon Interact, a Subsidiary of DatChat, To Launch "Trump Trivia" - A New AI-Generated Podcast for the Ultimate Political Trivia Experience

DatChat to Attend The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

DatChat Awarded New U.S. Patent for its Blockchain-Based Communications Systems and Methods

DatChat, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

Power Nickel (TSXV: PNPN) (OTCQB: PNPNF) CEO Unveils Game-Changing Developments in New Video – More Inside Watch Now!

DatChat to Debut Its New Myseum Forever Digital Shoebox Platform at RootsTech 2025

DatChat Awarded Mexican Patent for Advanced Digital Privacy Technology

DatChat Launches Myseum Social Media Platform for Apple iOS and Android Platforms

DatChat Announces Strategic Relationship Agreement between Myseum Social Media Platform and The Photo Managers for Digital Asset Organization

DatChat Receives Notice of Allowance for European Patent Application for Advanced Digital Privacy Technology

Comments

DatChat

DatChat (DATS) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル